EIF2B3 Antibody (N-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP1930b
Background:
EIF2B3 catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP. Mutations in each of the five subunits of translation initiation factor eIF2B, including subunit 3, can cause leukoencephalopathy with vanishing white matter. EIF2B3 has also been identified as a cofactor of hepatitis C virus internal ribosome entry site-mediated translation.
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1930b was selected from the N-term region of human EIF2B3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: EIF2B3 {ECO:0000313|EMBL:CAG33566.1}
Gene ID: 8891
Primary Accession: Q9HA31
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
EIF2B3 catalyzes the exchange of eukaryotic initiation factor 2-bound GDP for GTP. Mutations in each of the five subunits of translation initiation factor eIF2B, including subunit 3, can cause leukoencephalopathy with vanishing white matter. EIF2B3 has also been identified as a cofactor of hepatitis C virus internal ribosome entry site-mediated translation.
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP1930b was selected from the N-term region of human EIF2B3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: EIF2B3 {ECO:0000313|EMBL:CAG33566.1}
Gene ID: 8891
Primary Accession: Q9HA31
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review